Evidence map›Paper›PMID 37443184›Full record

ArticleScientific reports2023

Topic modeling for multi-omic integration in the human gut microbiome and implications for Autism.

Christine Tataru, Marie Peras, Erica Rutherford, Kaiti Dunlap, Xiaochen Yin, Brianna S Chrisman, Todd Z DeSantis, Dennis P Wall, Shoko Iwai, Maude M David

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Christine TataruDepartment of Microbiology, Oregon State University, SW Campus Way, Corvallis, USA. tataruc@oregonstate.edu.
Marie PerasSecond Genome Inc, 1000 Marina Blvd, Suite 500, Brisbane, CA, 94005, USA.
Erica RutherfordSecond Genome Inc, 1000 Marina Blvd, Suite 500, Brisbane, CA, 94005, USA.
Kaiti DunlapDepartment of Bioengineering, Serra Mall, Stanford, USA.
Xiaochen YinSecond Genome Inc, 1000 Marina Blvd, Suite 500, Brisbane, CA, 94005, USA.
Brianna S ChrismanDepartment of Bioengineering, Serra Mall, Stanford, USA.
Todd Z DeSantisSecond Genome Inc, 1000 Marina Blvd, Suite 500, Brisbane, CA, 94005, USA.
Dennis P WallDepartment of Biomedical Data Science, Serra Mall, Stanford, USA.
Shoko IwaiSecond Genome Inc, 1000 Marina Blvd, Suite 500, Brisbane, CA, 94005, USA.
Maude M DavidDepartment of Microbiology, Oregon State University, SW Campus Way, Corvallis, USA. maude.david@oregonstate.edu.

Funding

Development of a Commercial Platform for Discovery and Validation of Key Microbial Metabolites in CNS DisordersR44DA043954 · NIDA · SECOND GENOME, INC. · PI DESANTIS, TODD Z · 2017 to 2020
$2.1M
NIDA NIH HHS R44 DA043954
6 · The paper itself

Abstract

While healthy gut microbiomes are critical to human health, pertinent microbial processes remain largely undefined, partially due to differential bias among profiling techniques. By simultaneously integrating multiple profiling methods, multi-omic analysis can define generalizable microbial processes, and is especially useful in understanding complex conditions such as Autism. Challenges with integrating heterogeneous data produced by multiple profiling methods can be overcome using Latent Dirichlet Allocation (LDA), a promising natural language processing technique that identifies topics in heterogeneous documents. In this study, we apply LDA to multi-omic microbial data (16S rRNA amplicon, shotgun metagenomic, shotgun metatranscriptomic, and untargeted metabolomic profiling) from the stool of 81 children with and without Autism. We identify topics, or microbial processes, that summarize complex phenomena occurring within gut microbial communities. We then subset stool samples by topic distribution, and identify metabolites, specifically neurotransmitter precursors and fatty acid derivatives, that differ significantly between children with and without Autism. We identify clusters of topics, deemed "cross-omic topics", which we hypothesize are representative of generalizable microbial processes observable regardless of profiling method. Interpreting topics, we find each represents a particular diet, and we heuristically label each cross-omic topic as: healthy/general function, age-associated function, transcriptional regulation, and opportunistic pathogenesis.

Indexed as

Autistic DisorderGastrointestinal MicrobiomeMicrobiotaChildHumansMultiomicsRNA, Ribosomal, 16SRNA, Ribosomal, 16S

Identifiers

PMID37443184
PMCPMC10345091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.